SavedAdd your journal

Journals / Türk Nöroloji Dergisi / 2017 / Cilt: 23 - Sayı: 3

The Importance of Consultation Neurology: A Patient with Anti-Glutamic Acid Decarboxylase Antibody-Associated Cerebellar Ataxia Recognized in the Psychiatry Inpatient Clinic

Konsültasyon Nörolojisinin Önemi: Psikiyatri Servisinde Tanınan Anti-Glutamik Asit Dekarboksilaz Antikor İlişkili Serebellar Ataksi Hastası

Dilek ATAKLI
Betül GÜVELİ
Zeynep Ezgi BALÇIK
Sezin Alpaydın BASLO
Elif SÖYLEMEZ
Pages
142–143
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ATAKLI, D., GÜVELİ, B., BALÇIK, Z. E., BASLO, S. A., SÖYLEMEZ, E. (2022). The Importance of Consultation Neurology: A Patient with Anti-Glutamic Acid Decarboxylase Antibody-Associated Cerebellar Ataxia Recognized in the Psychiatry Inpatient Clinic. Türk Nöroloji Dergisi, Cilt: 23 - Sayı: 3, 142–143. https://ajindex.com/articles/636844

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Fernandes M, Munhoz RP, Carrilho PE, Arruda WO, Lorenzoni PJ, Scola RH, Werneck LC, Teive HA. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series. Arq Neuropsiquiatr 2012;70:657-661
  2. Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 2001;58:225-230
  3. Dalakas MC. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol 2005;252:119-125
  4. Hadjivassiliou M, Boscolo S, Tongiorgi E, Grünewald RA, Sharrack B, Sanders DS, Woodroofe N, Davies-Jones GA. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord 2008;23:1370-1377
  5. Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias 2015;2:14.